Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17150
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLaval, Marie-
dc.contributor.authorDumesny, Chelsea-
dc.contributor.authorEutick, Mal-
dc.contributor.authorBaldwin, Graham S-
dc.contributor.authorMarshall, Kathryn M-
dc.date.accessioned2018-02-14T02:24:54Z-
dc.date.available2018-02-14T02:24:54Z-
dc.date.issued2018-01-24-
dc.identifier.citationMetallomics : integrated biometal science 2018; 10(1): 194-200-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17150-
dc.description.abstractImmature forms of the peptide hormone gastrin have been implicated in the development of colorectal cancer (CRC). The biological activity of glycine-extended gastrin (Ggly) is dependent on the binding of Fe3+ ions in vitro and in vivo. The aim of the present study was to determine the effect of blocking Fe3+ ion binding to Ggly, using Bi3+, In3+ or Ru3+ ions, on the development of intestinal tumors in APCΔ14/+ mice. APCΔ14/+ mice were treated orally with Bi3+, In3+ or Ru3+ ions for up to 60 days, serum trace metals were analyzed by inductively coupled plasma mass spectrometry, and the incidence and size of intestinal tumors were assessed. Bi3+ treatment significantly decreased the number of tumors larger than 3 mm in male mice. In3+ or Ru3+ treatment significantly increased the tumor burden in all animals and In3+ increased the number of tumors larger than 3 mm or 5 mm in male mice alone. The fact that binding of In3+ or Ru3+ ions to Ggly was orders of magnitude stronger than the binding of Bi3+ ions implies that the inhibitory effect of Bi3+ ions is not a consequence of a reduction in Ggly activity. However, further testing of higher doses of Bi3+ ions for longer periods as an oral treatment for intestinal tumors is warranted.-
dc.language.isoeng-
dc.titleOral trivalent bismuth ions decrease, and trivalent indium or ruthenium ions increase, intestinal tumor burden in ApcΔ14/+ mice.-
dc.typeJournal Article-
dc.identifier.journaltitleMetallomics : integrated biometal science-
dc.identifier.affiliationUniversity of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationPhebra Pty. Ltd., Lane Cove West, New South Wales, Australia-
dc.identifier.doi10.1039/c7mt00272f-
dc.identifier.pubmedid29296993-
dc.type.austinJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Mar 3, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.